181 related articles for article (PubMed ID: 37560801)
1.
Carbo-Meix A; Guijarro F; Wang L; Grau M; Royo R; Frigola G; Playa-Albinyana H; Buhler MM; Clot G; Duran-Ferrer M; Lu J; Granada I; Baptista MJ; Navarro JT; Espinet B; Puiggros A; Tapia G; Bandiera L; De Canal G; Bonoldi E; Climent F; Ribera-Cortada I; Fernandez-Caballero M; De la Banda E; Do Nascimento J; Pineda A; Vela D; Rozman M; Aymerich M; Syrykh C; Brousset P; Perera M; Yanez L; Ortin JX; Tuset E; Zenz T; Cook JR; Swerdlow SH; Martin-Subero JI; Colomer D; Matutes E; Bea S; Costa D; Nadeu F; Campo E
Haematologica; 2024 Feb; 109(2):493-508. PubMed ID: 37560801
[TBL] [Abstract][Full Text] [Related]
2. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
[TBL] [Abstract][Full Text] [Related]
4. Splenic small B-cell lymphoma with IGH/BCL3 translocation.
Soma LA; Gollin SM; Remstein ED; Ketterling RP; Flynn HC; Rajasenan KK; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):218-30. PubMed ID: 16426923
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.
Martín-Subero JI; Ibbotson R; Klapper W; Michaux L; Callet-Bauchu E; Berger F; Calasanz MJ; De Wolf-Peeters C; Dyer MJ; Felman P; Gardiner A; Gascoyne RD; Gesk S; Harder L; Horsman DE; Kneba M; Küppers R; Majid A; Parry-Jones N; Ritgen M; Salido M; Solé F; Thiel G; Wacker HH; Oscier D; Wlodarska I; Siebert R
Leukemia; 2007 Jul; 21(7):1532-44. PubMed ID: 17495977
[TBL] [Abstract][Full Text] [Related]
6. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases.
Michaux L; Dierlamm J; Wlodarska I; Bours V; Van den Berghe H; Hagemeijer A
Cancer Genet Cytogenet; 1997 Mar; 94(1):36-43. PubMed ID: 9078289
[TBL] [Abstract][Full Text] [Related]
7. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
[TBL] [Abstract][Full Text] [Related]
10. The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy.
Schweighofer CD; Huh YO; Luthra R; Sargent RL; Ketterling RP; Knudson RA; Barron LL; Medeiros LJ; Keating MJ; Abruzzo LV
Int J Cancer; 2011 Jun; 128(11):2759-64. PubMed ID: 20715110
[TBL] [Abstract][Full Text] [Related]
11. Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia.
Alpatov R; Carstens B; Harding K; Jarrett C; Balakhani S; Lincoln J; Brzeskiewicz P; Guo Y; Ohene-Mobley A; LeRoux J; McDaniel V; Meltesen L; Minka D; Patel M; Manavi C; Swisshelm K
Mol Cytogenet; 2015; 8():101. PubMed ID: 26719766
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
13. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Fang H; Reichard KK; Rabe KG; Hanson CA; Call TG; Ding W; Kenderian SS; Muchtar E; Schwager SM; Leis JF; Chanan-Khan AA; Slager SL; Braggio E; Smoley SA; Kay NE; Shanafelt TD; Van Dyke DL; Parikh SA
Am J Hematol; 2019 Mar; 94(3):338-345. PubMed ID: 30575108
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia.
Yabumoto K; Ohno H; Doi S; Edamura S; Arita Y; Akasaka T; Matsumoto J; Kadowaki N; Fukuhara S; Okuma M
Int J Hematol; 1994 Apr; 59(3):211-8. PubMed ID: 8011990
[TBL] [Abstract][Full Text] [Related]
15. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
Kuper-Hommel MJ; Schreuder MI; Gemmink AH; van Krieken JH
Mod Pathol; 2013 Mar; 26(3):421-7. PubMed ID: 23018871
[TBL] [Abstract][Full Text] [Related]
16. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
[TBL] [Abstract][Full Text] [Related]
17. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders.
Michaux L; Mecucci C; Stul M; Wlodarska I; Hernandez JM; Meeus P; Michaux JL; Scheiff JM; Noël H; Louwagie A; Criel A; Boogaerts M; Van Orshoven A; Cassiman JJ; Van Den Berghe H
Genes Chromosomes Cancer; 1996 Jan; 15(1):38-47. PubMed ID: 8824724
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes.
Yin CC; Lin KI; Ketterling RP; Knudson RA; Medeiros LJ; Barron LL; Huh YO; Luthra R; Keating MJ; Abruzzo LV
Am J Clin Pathol; 2009 May; 131(5):663-70. PubMed ID: 19369625
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
[TBL] [Abstract][Full Text] [Related]
20. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J
Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
